| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |